proxyvotesnow.com

Home › Upcoming votes › NANOVIRICIDES, INC.

NANOVIRICIDES, INC. Annual Meeting November 21, 2026: What's on the Ballot

The deadline as the proxy statement states it: “proxy card retains the right to revoke such proxy card by: (i) submitting a written notice of such revocation to the Secretary of the Company so that it is received no later than 5:00 p.m. (New York City time) on November 19, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.

Read the proxy statement on EDGAR

What’s on the ballot

Ballot read from the proxy statement and checked. As listed in NANOVIRICIDES, INC.’s proxy statement, with the board’s recommendation on each item.

#ItemProposed byBoard recommendsLast year (same kind of item)
1 Re-election of Class I and Class II directors
Director election
Board For 98% support for the one nominee
2 Ratify appointment of EisnerAmper LLP
Auditor
Board For 99% support
3 Procedural matters including postponement to solicit additional proxies
Adjournment
Board For —

Last year’s official results

From NANOVIRICIDES, INC.’s Form 8-K, filed November 26, 2025, for the meeting held November 22, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.

ItemSupport (of votes cast)Reported outcome
Elect Director: Anil Diwan98%—
2. Advisory Vote on Executive Compensation – To conduct an advisory vote on the compensation of the Company's named Executive Officers96%—
3. Ratification of Accounting Firm – To ratify the appointment of EisnerAmper, LLP as the Company's independent registered public accounting99%—

Filings for this meeting

About this page

The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.